Company gets Government approval to test Cannabis for Alzheimer’s
Cannabis News
January 6, 2023
No objection letter allows the company to explore drug formulation for easing dementia-related agitation. India Globalization Capital, Inc. (IGC) has received a green light to move forward with a Phase 2 trial exploring the efficacy of its drug formulation on Alzheimer’s disease-related agitation
Read More: Company gets Government approval to test Cannabis for Alzheimer’s
Comments are closed, but trackbacks and pingbacks are open.